Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Risk Factor Identified for Gastrointestinal Disorder in Neonates

By LabMedica International staff writers
Posted on 08 Dec 2011
A major risk factor has been identified in premature infants who suffer from the life-threatening destruction of intestinal tissue.

Premature newborns that develop the medical condition called necrotizing enterocolitis (NEC), and have the AB blood type are nearly three times as likely to die from it as preemies with other blood types. More...


Doctors at Loyola University Medical Center (Maywood, IL, USA) examined records of 276 preemies in their neonatal intensive care unit (ICU) who suffered severe NEC during the last 24 years. Preemies often require multiple blood transfusions. Neonatal ICUs typically give Type O, the universal donor type, but this practice may inadvertently cause an enhanced immune reaction. This reaction, in turn, could be a reason why AB babies who develop NEC have a higher mortality.

The investigators found that AB preemies were 2.87 times more likely to die from NEC than babies with other blood types were. The significant difference in survival within the group of AB neonates is not only due to the disproportionate frequency of their demise (43%), but also to their short survival times. NEC likely involves several factors, including a decrease in blood flow to the bowel, infection, mechanical injury, and abnormal immune response. NEC occurs when the lining of the intestinal wall dies and tissue falls off. Most cases of NEC are mild to moderate and can be successfully treated with antibiotics. However, in severe cases, a hole can develop in the intestine, allowing bacteria to leak into the abdomen and causing a life-threatening infection.

The investigators suggested it may be prudent to change transfusion practices so that preemies receive their specific blood types, rather than the universal donor Type O. Jonathan Muraskas, MD, senior author of the study said "Although this will likely not eradicate NEC, it is an easily modifiable factor that may help to prevent those cases of NEC that develop in relation to the transfusion of blood products". The study was published on November 17, 2011, in the Journal of Perinatology.

Related Links:

Loyola University Medical Center


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.